Reporting standards for angioplasty and stent-assisted angioplasty for intracranial atherosclerosis

Stroke

Volumn 40, Issue 5, 2009, Pages

  Schumacher, H Christian ^a   Meyers, Philip M ^b,i   Higashida, Randall T ^c   Derdeyn, Colin P ^d   Lavine, Sean D ^b   Nesbit, Gary M ^e   Sacks, David ^f   Rasmussen, Peter ^h   Wechsler, Lawrence R ^g  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b Neurological Institute of New York ^*  (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^f READING HOSPITAL AND MEDICAL CENTER   (United States)

^g UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^h LERNER RESEARCH INSTITUTE   (United States)

ⁱ NEUROLOGICAL INSTITUTE   (United States)

Author keywords

Anatomy; Angiography; Interventional neuroradiology; Neuroradiology; Reporting standard; Reporting terminology; Stenting

Indexed keywords

ABCIXIMAB; ACETYLCYSTEINE; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; BICARBONATE; CLOPIDOGREL; GLYCERYL TRINITRATE; HEPARIN; HYPERTENSIVE FACTOR; ISOSORBIDE DINITRATE; LOW MOLECULAR WEIGHT HEPARIN; NICARDIPINE; NIMODIPINE; VERAPAMIL;

ANGIOPLASTY; ARTERY OCCLUSION; ARTICLE; BLOOD VESSEL PERFORATION; BOLUS INJECTION; BRAIN ATHEROSCLEROSIS; BRAIN ISCHEMIA; CATHETERIZATION; CLINICAL EVALUATION; CLINICAL TRIAL; CONTINUOUS INFUSION; DATA BASE; HUMAN; PATIENT SELECTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; RESTENOSIS; RISK ASSESSMENT; STENOSIS; STENT; TREATMENT FAILURE; AGED; ANESTHESIA; ATHEROSCLEROSIS; CAROTID ARTERY OBSTRUCTION; CEREBRAL REVASCULARIZATION; CEREBROVASCULAR DISEASE; COMORBIDITY; DOCUMENTATION; FEMALE; GRAFT OCCLUSION; MALE; MIDDLE AGED; NEUROSURGERY; PATHOLOGY; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR; STANDARD; STENOSIS, OCCLUSION AND OBSTRUCTION; STROKE; TREATMENT OUTCOME;

AGED; ANESTHESIA; ANGIOPLASTY; ANGIOPLASTY, BALLOON; ATHEROSCLEROSIS; BRAIN ISCHEMIA; CAROTID STENOSIS; CEREBRAL REVASCULARIZATION; CEREBROVASCULAR DISORDERS; COMORBIDITY; CONSTRICTION, PATHOLOGIC; DOCUMENTATION; FEMALE; GRAFT OCCLUSION, VASCULAR; GUIDELINES AS TOPIC; HUMANS; MALE; MIDDLE AGED; NEUROSURGICAL PROCEDURES; RISK FACTORS; STENTS; STROKE; TREATMENT OUTCOME;

EID: 65549153509     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.108.527580     Document Type: Article

References (180)

1. Schumacher HC, Meyers PM, Mohr JP, Higashida R. Elective angioplasty and stenting for intracranial atherosclerosis. In: Al-Mubarak N, Rubin GS, Iyer SS, Vitek JJ, eds. Carotid Artery Stenting: Current Practice and Techniques. New York: Lippincott; 2003.
2. SSYLVIA Investigators. Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results. Stroke. 2004;35:1388-1392.
3. Bose A, Hartmann M, Henkes H, Liu HM, Teng MM, Szikora I, Berlis A, Reul J, Yu SC, Forsting M, Lui M, Lim W, Sit SP. A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses. The Wing Span Study. Stroke. 2007;38:1531-1537.
4. Higashida RT, Meyers PM, Connors JJ III, Sacks D, Strother CM, Barr JD, Wojak JC, Duckwiler GR. Intracranial angioplasty & stenting for cerebral atherosclerosis: a position statement of the American Society of Interventional and Therapeutic Neuroradiology, Society of Interven-tional Radiology, and the American Society of Neuroradiology. AJNR Am J Neuroradiol. 2005;26:2323-2327.
5. SAMMPRIS. Stenting vs Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis. Available at: http:// clinicaltrials.gov/ct2/show/NCT00576693?term=SAMMPRIS&rank=1. Accessed October 26, 2008.
6. Kremer C, Schaettin T, Georgiadis D, Baumgartner RW. Prognosis of asymptomatic stenosis of the middle cerebral artery. J Neurol Neurosurg Psychiatry. 2004;75:1300-1303.
7. Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. Md State Med J. 1965;14:61-65.
8. Stineman MG, Shea JA, Jette A, Tassoni CJ, Ottenbacher KJ, Fiedler R, Granger CV. The Functional Independence Measure: tests of scaling assumptions, structure, and reliability across 20 diverse impairment categories. Arch Phys Med Rehabil. 1996;77:1101-1108.
9. de Haan R, Limburg M, Bossuyt P, van der MJ, Aaronson N. The clinical meaning of Rankin 'handicap' grades after stroke. Stroke. 1995; 26:2027-2030.
10. Brott T, Adams HP Jr, Olinger CP, Marler JR, Barsan WG, Biller J, Spilker J, Holleran R, Eberle R, Hertzberg V. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989;20: 864-870.
11. The Internet Stroke Center. Stroke Scales & Clinical Assessment Tools. Available at: www.strokecenter.org/trials/scales/scales-overview.htm. Accessed October 26, 2008.
12. National Institute of Neurological Disorders and Stroke. NIH Stroke Scale Training. Available at: www.ninds.nih.gov/doctors/stroke-scale-training.htm. Accessed October 26, 2008.
13. Wilson JT, Hareendran A, Grant M, Baird T, Schulz UG, Muir KW, Bone I. Improving the assessment of outcomes in stroke: use of a structured interview to assign grades on the modified Rankin Scale. Stroke. 2002;33:2243-2246.
14. Lees KR, Zivin JA, Ashwood T, Davalos A, Davis SM, Diener HC, Grotta J, Lyden P, Shuaib A, Hardemark HG, Wasiewski WW. NXY-059 for acute ischemic stroke. N Engl J Med. 2006;354:588-600.
15. Naritomi H, Sawada T, Kuriyama Y, Kinugawa H, Kaneko T, Takamiya M. Effect of chronic middle cerebral artery stenosis on the local cerebral hemodynamics. Stroke. 1985;16:214-219.
16. Derdeyn CP, Powers WJ, Grubb RL Jr. Hemodynamic effects of middle cerebral artery stenosis and occlusion. AJNR Am J Neuroradiol. 1998; 19:1463-1469.
17. Castaigne P, Lhermitte F, Gautier JC, Escourolle R, Derouesne C, Der AP, Popa C. Arterial occlusions in the vertebro-basilar system. A study of 44 patients with post-mortem data. Brain. 1973;96:133-154.
18. Constantinides P. Pathogenesis of cerebral artery thrombosis in man. Arch Pathol. 1967;83:422-428.
19. Lhermitte F, Gautier JC, Derouesne C. Nature of occlusions of the middle cerebral artery. Neurology. 1970;20:82-88.
20. Ogata J, Masuda J, Yutani C, Yamaguchi T. Mechanisms of cerebral artery thrombosis: a histopathological analysis on eight necropsy cases. J Neurol Neurosurg Psychiatry. 1994;57:17-21.
21. Sadoshima S, Fukushima T, Tanaka K. Cerebral artery thrombosis and intramural hemorrhage. Stroke. 1979;10:411-414.
22. Hinton RC, Mohr JP, Ackerman RH, Adair LB, Fisher CM. Symptomatic middle cerebral artery stenosis. Ann Neurol. 1979;5:152-157.
23. Corston RN, Kendall BE, Marshall J. Prognosis in middle cerebral artery stenosis. Stroke. 1984;15:237-241.
24. Koroshetz WJ, Ropper AH. Artery-to-artery embolism causing stroke in the posterior circulation. Neurology. 1987;37:292-295.
25. Masuda J, Ogata J, Yutani C, Miyashita T, Yamaguchi T. Artery-to-artery embolism from a thrombus formed in stenotic middle cerebral artery. Report of an autopsy case. Stroke. 1987;18:680-684.
26. Segura T, Serena J, Castellanos M, Teruel J, Vilar C, Davalos A. Embolism in acute middle cerebral artery stenosis. Neurology. 2001;56: 497-501.
27. Wong KS, Gao S, Lam WW, Chan YL, Kay R. A pilot study of microembolic signals in patients with middle cerebral artery stenosis. J Neuroimaging. 2001;11:137-140.
28. Fisher CM, Caplan LR. Basilar artery branch occlusion: a cause of pontine infarction. 1971;21:900-905.
29. Fisher CM. Bilateral occlusion of basilar artery branches. J Neurol Neurosurg Psychiatry. 1977;40:1182-1189.
30. Bogousslavsky J, Barnett HJ, Fox AJ, Hachinski VC, Taylor W. Atherosclerotic disease of the middle cerebral artery. Stroke. 1986;17: 1112-1120.
31. Caplan L, Babikian V, Helgason C, Hier DB, DeWitt D, Patel D, Stein R. Occlusive disease of the middle cerebral artery. Neurology. 1985;35: 975-982.
32. Lyrer PA, Engelter S, Radu EW, Steck AJ. Cerebral infarcts related to isolated middle cerebral artery stenosis. Stroke. 1997;28:1022-1027.
33. Mull M, Schwarz M, Thron A. Cerebral hemispheric low-flow infarcts in arterial occlusive disease. Lesion patterns and angiomorphological conditions. Stroke. 1997;28:118-123.
34. Felberg RA, Christou I, Demchuk AM, Malkoff M, Alexandrov AV. Screening for intracranial stenosis with transcranial Doppler: the accuracy of mean flow velocity thresholds. J Neuroimaging. 2002; 12:9-14.
35. Hirai T, Korogi Y, Ono K, Nagano M, Maruoka K, Uemura S, Takahashi M. Prospective evaluation of suspected stenoocclusive disease of the intracranial artery: combined MR angiography and CT angiography compared with digital subtraction angiography. AJNR Am J Neuroradiol. 2002;23:93-101.
36. Bash S, Villablanca JP, Jahan R, Duckwiler G, Tillis M, Kidwell C, Saver J, Sayre J. Intracranial vascular stenosis and occlusive disease: evaluation with CT angiography, MR angiography, and digital subtraction angiography. AJNR Am J Neuroradiol. 2005;26:1012-1021.
37. Willinek WA, von Falkenhausen M, Born M, Gieseke J, Holler T, Klockgether T, Textor HJ, Schild HH, Urbach H. Noninvasive detection of steno-occlusive disease of the supra-aortic arteries with three-dimensional contrast-enhanced magnetic resonance angiography: a prospective, intra-individual comparative analysis with digital subtraction angiography. Stroke. 2005;36:38-43.
38. Wright VL, Olan W, Dick B, Yu H, Alberts-Grill N, Latour LL, Baird AE. Assessment of CE-MRA for the rapid detection of supra-aortic vascular disease. Neurology. 2005;65:27-32.
39. Villablanca JP, Nael K, Habibi R, Nael A, Laub G, Finn JP. 3 T contrast-enhanced magnetic resonance angiography for evaluation of the intracranial arteries: comparison with time-of-flight magnetic resonance angiography and multislice computed tomography angiography. Invest Radiol. 2006;41:799-805.
40. Feldmann E, Wilterdink JL, Kosinski A, Lynn M, Chimowitz MI, Sarafin J, Smith HH, Nichols F, Rogg J, Cloft HJ, Wechsler L, Saver J, Levine SR, Tegeler C, Adams R, Sloan M. The Stroke Outcomes and Neuroimaging of Intracranial Atherosclerosis (SONIA) Trial. Neurology. 2007;68:2099-2106.
41. Derdeyn CP, Grubb RL Jr, Powers WJ. Cerebral hemodynamic impairment: methods of measurement and association with stroke risk. Neurology. 1999;53:251-259.
42. Furukawa M, Kashiwagi S, Matsunaga N, Suzuki M, Kishimoto K, Shirao S. Evaluation of cerebral perfusion parameters measured by perfusion CT in chronic cerebral ischemia: comparison with xenon CT. J Comput Assist Tomogr. 2002;26:272-278.
43. Kikuchi K, Murase K, Miki H, Kikuchi T, Sugawara Y, Mochizuki T, Ikezoe J, Ohue S. Measurement of cerebral hemodynamics with perfusion-weighted MR imaging: comparison with pre-and post-acet-azolamide 133Xe-SPECT in occlusive carotid disease. AJNR Am J Neuroradiol. 2001;22:248-254.
44. Kim JH, Lee SJ, Shin T, Kang KH, Choi PY, Kim JH, Gong JC, Choi NC, Lim BH. Correlative assessment of hemodynamic parameters obtained with T2ß-weighted perfusion MR imaging and SPECT n symptomatic carotid artery occlusion. AJNR Am J Neuroradiol. 2000; 21:1450-1456.
45. Lythgoe DJ, Williams SC, Cullinane M, Markus HS. Mapping of cere-brovascular reactivity using BOLD magnetic resonance imaging. Magn Reson Imaging. 1999;17:495-502.
46. Lythgoe DJ, Ostergaard L, William SC, Cluckie A, Buxton-Thomas M, Simmons A, Markus HS. Quantitative perfusion imaging in carotid artery stenosis using dynamic susceptibility contrast-enhanced magnetic resonance imaging. Magn Reson Imaging. 2000;18:1-11.
47. Ozgur HT, Kent WT, Masaryk A, Seeger JF, Williams W, Krupinski E, Melgar M, Labadie E. Correlation of cerebrovascular reserve as measured by acetazolamide-challenged SPECT with angiographic flow patterns and intra-or extracranial arterial stenosis. AJNR Am J Neuro-radiol. 2001;22:928-936.
48. Thijs VN, Albers GW. Symptomatic intracranial atherosclerosis: outcome of patients who fail antithrombotic therapy. Neurology. 2000; 55:490-497.
49. Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chaturvedi S, Kasner SE, Benesch CG, Sila CA, Jovin TG, Romano JG. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med. 2005;352: 1305-1316.
50. Kasner SE, Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chaturvedi S, Benesch CG, Sila CA, Jovin TG, Romano JG, Cloft HJ. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation. 2006;113:555-563.
51. Gupta R, Schumacher HC, Mangla S, Meyers PM, Duong H, Khandji AG, Marshall RS, Mohr JP, Pile-Spellman J. Urgent endovascular re-vascularization for symptomatic intracranial atherosclerotic stenosis. Neurology. 2003;61:1729-1735.
52. Bose A, Hartmann M, Henkes H, Liu HM, Teng MM, Szikora I, Berlis A, Reul J, Yu SC, Forsting M, Lui M, Lim W, Sit SP. A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses. The WingSpan Study. Stroke. 2007;38:1531-1537.
53. US Food and Drug Administration. WingSpan Stent System and Gateway PTA Balloon Catheter. Summary of Safety and Probable Benefit. Available at: www.fda.gov/cdrh/pdf5/h050001b.pdf. Accessed October 26, 2008.
54. Kim JK, Ahn JY, Lee BH, Chung YS, Chung SS, Kim OJ, Kim WC, Joo JY. Elective stenting for symptomatic middle cerebral artery stenosis presenting as transient ischaemic deficits or stroke attacks: short term arteriographical and clinical outcome. J Neurol Neurosurg Psychiatry. 2004;75:847-851.
55. Rothwell PM, Gibson RJ, Slattery J, Sellar RJ, Warlow CP. Equivalence of measurements of carotid stenosis. A comparison of three methods on 1001 angiograms. European Carotid Surgery Trialists' Collaborative Group. Stroke. 1994;25:2435-2439.
56. Rothwell PM, Gibson RJ, Slattery J, Warlow CP. Prognostic value and reproducibility of measurements of carotid stenosis. A comparison of three methods on 1001 angiograms. European Carotid Surgery Trialists' Collaborative Group. Stroke. 1994;25:2440-2444.
57. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. North American Symptomatic Carotid End-arterectomy Trial Collaborators. N Engl J Med. 1991;325:445-453.
58. Yokote H, Terada T, Ryujin K, Konoshita Y, Tsuura M, Nakai E, Kamei I, Moriwaki H, Hayashi S, Itakura T. Percutaneous transluminal angio-plasty for intracranial arteriosclerotic lesions. Neuroradiology. 1998;40: 590-596.
59. Weber W, Mayer TE, Henkes H, Kis B, Hamann GF, Schulte-Altedorneburg G, Brueckmann H, Kuehne D. Stent-angioplasty of intra-cranial vertebral and basilar artery stenoses in symptomatic patients. Eur J Radiol. 2005;55:231-236.
60. Lee TH, Kim DH, Lee BH, Kim HJ, Choi CH, Park KP, Jung DS, Kim S, Moon TY. Preliminary results of endovascular stent-assisted angio-plasty for symptomatic middle cerebral artery stenosis. AJNR Am J Neuroradiol. 2005;26:166-174.
61. Straube T, Stingele R, Jansen O. Primary stenting of intracranial atherosclerotic stenoses. Cardiovasc Intervent Radiol. 2005;28:289-295.
62. Samuels OB, Joseph GJ, Lynn MJ, Smith HA, Chimowitz MI. A standardized method for measuring intracranial arterial stenosis. AJNR Am J Neuroradiol. 2000;21:643-646.
63. Marks MP, Wojak JC, Al-Ali F, Jayaraman M, Marcellus ML, Connors JJ, Do HM. Angioplasty for symptomatic intracranial stenosis. Clinical outcome. Stroke. 2006;37:1016-1020.
64. Bartlett ES, Walters TD, Symons SP, Fox AJ. Quantification of carotid stenosis on CT angiography. AJNR Am J Neuroradiol. 2006;27:13-19.
65. Bartlett ES, Symons SP, Fox AJ. Correlation of carotid stenosis diameter and cross-sectional areas with CT angiography. AJNR Am J Neuro-radiol. 2006;27:638-642.
66. Bartlett ES, Walters TD, Symons SP, Fox AJ. Carotid stenosis index revisited with direct CT angiography measurement of carotid arteries to quantify carotid stenosis. Stroke. 2007;38:286-291.
67. Yamura M, Hirai T, Korogi Y, Ikushima I, Yamashita Y. Quantitative evaluation of measurement accuracy for three-dimensional angiography system using various phantoms. Radiat Med. 2005;23:175-181.
68. Mori T, Fukuoka M, Kazita K, Mori K. Follow-up study after intra-cranial percutaneous transluminal cerebral balloon angioplasty. AJNR Am J Neuroradiol. 1998;19:1525-1533.
69. Mori T, Mori K, Fukuoka M, Arisawa M, Honda S. Percutaneous transluminal cerebral angioplasty: serial angiographic follow-up after successful dilatation. Neuroradiology. 1997;39:111-116.
70. Jiang WJ, Wang YJ, Du B, Wang SX, Wang GH, Jin M, Dai JP. Stenting of symptomatic M1 stenosis of middle cerebral artery: an initial experience of 40 patients. Stroke. 2004;35:1375-1380.
71. Chaturvedi S, St Pierre ME, Bertasio B. Cerebral angioplasty practice at major medical centers in the United States. Neuroradiology. 2000;42: 218-220.
72. Hobson RW, II, Howard VJ, Roubin GS, Ferguson RD, Brott TG, Howard G, Sheffet AJ, Roberts J, Hopkins LN, Moore WS. Creden-tialing of surgeons as interventionalists for carotid artery stenting: experience from the lead-in phase of CREST. J Vasc Surg. 2004;40:952-957.
73. Featherstone RL, Brown MM, Coward LJ. International carotid stenting study: protocol for a randomised clinical trial comparing carotid stenting with endarterectomy in symptomatic carotid artery stenosis. Cere-brovasc Dis. 2004;18:69-74.
74. EVA-3S Trialists. Endarterectomy vs Angioplasty in Patients with Symptomatic Severe Carotid Stenosis (EVA-3S) Trial. Cerebrovasc Dis. 2004;18:62-65.
75. Connors JJ III, Sacks D, Furlan AJ, Selman WR, Russell EJ, Stieg PE, Hadley MN. Training, competency, and credentialing standards for diagnostic cervicocerebral angiography, carotid stenting, and cerebro-vascular intervention: a joint statement from the American Academy of Neurology, the American Association of Neurological Surgeons, the American Society of Interventional and Therapeutic Neuroradiology, the Am Society of Neuroradiology, the Congress of Neurological Surgeons, the AANS/CNS Cerebrovascular Section, and the Society of Interventional Radiology. J Vasc Interv Radiol. 2004;15:1347-1356.
76. Amorosi SL, Tsilimingras K, Thompson D, Fanikos J, Weinstein MC, Goldhaber SZ. Cost analysis of 'bridging therapy' with low-molecular-weight heparin versus unfractionated heparin during temporary interruption of chronic anticoagulation. Am J Cardiol. 2004;93:509-511.
77. Spyropoulos AC, Frost FJ, Hurley JS, Roberts M. Costs and clinical outcomes associated with low-molecular-weight heparin vs unfrac-tionated heparin for perioperative bridging in patients receiving long-term oral anticoagulant therapy. Chest. 2004;125:1642-1650.
78. Spyropoulos AC, Turpie AG, Dunn AS, Spandorfer J, Douketis J, Jacobson A, Frost FJ. Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: the REGIMEN registry. J Thromb Haemost. 2006;4:1246-1252.
79. Beldi G, Beng L, Siegel G, Bisch-Knaden S, Candinas D. Prevention of perioperative thromboembolism in patients with atrial fibrillation. Br J Surg. 2007;94:1351-1355.
80. Merten GJ, Burgess WP, Gray LV, Holleman JH, Roush TS, Kowalchuk GJ, Bersin RM, Van Moore A, Simonton CA III, Rittase RA, Norton HJ, Kennedy TP. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA. 2004;291: 2328-2334.
81. Liu R, Nair D, Ix J, Moore DH, Bent S. N-acetylcysteine for the prevention of contrast-induced nephropathy. A systematic review and meta-analysis. J Gen Intern Med. 2005;20:193-200.
82. Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M, Leys D, Matias-Guiu J, Rupprecht HJ. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet. 2004;364:331-337.
83. Takis C, Kwan ES, Pessin MS, Jacobs DH, Caplan LR. Intracranial angioplasty: experience and complications. AJNR Am J Neuroradiol. 1997;18:1661-1668.
84. Connors JJ III, Wojak JC. Percutaneous transluminal angioplasty for intracranial atherosclerotic lesions: evolution of technique and short-term results. J Neurosurg. 1999;91:415-423.
85. Jiang WJ, Du B, Leung TW, Xu XT, Wang YL, Wang YJ, Dai JP, Cerebrovascular complications of stent-assisted angioplasty in symptomatic intracranial arterial stenosis [abstract P72]. Stroke. 2006;37.
86. Kim DJ, Lee BH, Kim DI, Shim WH, Jeon P, Lee TH. Stent-assisted angioplasty of symptomatic intracranial vertebrobasilar artery stenosis: feasibility and follow-up results. AJNR Am J Neuroradiol. 2005;26: 1381-1388.
87. Gress DR, Smith WS, Dowd CF, Van H, V, Finley RJ, Higashida RT. Angioplasty for intracranial symptomatic vertebrobasilar ischemia. Neurosurgery. 2002;51:23-27.
88. Henkes H, Miloslavski E, Lowens S, Reinartz J, Liebig T, Kuhne D. Treatment of intracranial atherosclerotic stenoses with balloon dilatation and self-expanding stent deployment (WingSpan). Neuroradiology. 2005;47:222-228.
89. Kessler IM, Mounayer C, Piotin M, Spelle L, Vanzin JR, Moret J. The use of balloon-expandable stents in the management of intracranial arterial diseases: a 5-year single-center experience. AJNR Am J Neuro-radiol. 2005;26:2342-2348.
90. Dorros G, Cohn JM, Palmer LE. Stent deployment resolves a petrous carotid artery angioplasty dissection. AJNR Am J Neuroradiol. 1998;19: 392-394.
91. Jaeger HJ, Mathias KD, Drescher R, Hauth E, Bockisch G, Demirel E, Gissler HM. Diffusion-weighted MR imaging after angioplasty or angio-plasty plus stenting of arteries supplying the brain. AJNR Am J Neuro-radiol. 2001;22:1251-1259.
92. Lylyk P, Cohen JE, Ceratto R, Ferrario A, Miranda C. Angioplasty and stent placement in intracranial atherosclerotic stenoses and dissections. AJNR Am J Neuroradiol. 2002;23:430-436.
93. Lylyk P, Cohen JE, Ceratto R, Ferrario A, Miranda C. Endovascular reconstruction of intracranial arteries by stent placement and combined techniques. J Neurosurg. 2002;97:1306-1313.
94. Levy EI, Boulos AS, Guterman LR. Stent-assisted endoluminal revas-cularization for the treatment of intracranial atherosclerotic disease. Neurol Res. 2002;24:337-346.
95. Levy EI, Hanel RA, Boulos AS, Bendok BR, Kim SH, Gibbons KJ, Qureshi AI, Guterman LR, Hopkins LN. Comparison of periprocedure complications resulting from direct stent placement compared with those due to conventional and staged stent placement in the basilar artery. J Neurosurg. 2003;99:653-660.
96. Qureshi AI, Suri MF, Siddiqui AM, Kim SH, Boulos AS, Ringer AJ, Lopes DK, Guterman LR, Hopkins LN. Clinical and angiographic results of dilatation procedures for symptomatic intracranial atherosclerotic disease. J Neuroimaging. 2005;15:240-249.
97. Levy EI, Hanel RA, Bendok BR, Boulos AS, Hartney ML, Guterman LR, Qureshi AI, Hopkins LN. Staged stent-assisted angioplasty for symptomatic intracranial vertebrobasilar artery stenosis. J Neurosurg. 2002;97:1294-1301.
98. McKenzie JD, Wallace RC, Dean BL, Flom RA, Khayata MH. Preliminary results of intracranial angioplasty for vascular stenosis caused by atherosclerosis and vasculitis. AJNR Am J Neuroradiol. 1996;17: 263-268.
99. Marks MP, Marcellus M, Norbash AM, Steinberg GK, Tong D, Albers GW. Outcome of angioplasty for atherosclerotic intracranial stenosis. Stroke. 1999;30:1065-1069.
100. Nahser HC, Henkes H, Weber W, Berg-Dammer E, Yousry TA, Kuhne D. Intracranial vertebrobasilar stenosis: angioplasty and follow-up. AJNR Am J Neuroradiol. 2000;21:1293-1301.
101. Qureshi AI, Saad M, Zaidat OO, Suarez JI, Alexander MJ, Fareed M, Suri K, Ali Z, Hopkins LN. Intracerebral hemorrhages associated with neurointerventional procedures using a combination of antithrombotic agents including abciximab. Stroke. 2002;33:1916-1919.
102. Mori T, Fukuoka M, Kazita K, Mori K. Follow-up study after percutaneous transluminal cerebral angioplasty. Eur Radiol. 1998;8:403-408.
103. Mori T, Kazita K, Chokyu K, Mima T, Mori K. Short-term arterio-graphic and clinical outcome after cerebral angioplasty and stenting for intracranial vertebrobasilar and carotid atherosclerotic occlusive disease. AJNR Am J Neuroradiol. 2000;21:249-254.
104. van Mook WN, Rennenberg RJ, Schurink GW, van Oostenbrugge RJ, Mess WH, Hofman PA, de Leeuw PW. Cerebral hyperperfusion syndrome. Lancet Neurol. 2005;4:877-888.
105. Kaku Y, Yoshimura S, Kokuzawa J. Factors predictive of cerebral hyperperfusion after carotid angioplasty and stent placement. AJNR Am J Neuroradiol. 2004;25:1403-1408.
106. Gossetti B, Martinelli O, Guerricchio R, Irace L, Benedetti-Valentini F. Transcranial Doppler in 178 patients before, during, and after carotid endarterectomy. J Neuroimaging. 1997;7:213-216.
107. Dalman JE, Beenakkers IC, Moll FL, Leusink JA, Ackerstaff RG. Transcranial Doppler monitoring during carotid endarterectomy helps to identify patients at risk of postoperative hyperperfusion. Eur J Vasc Endovasc Surg. 1999;18:222-227.
108. Meyers PM, Higashida RT, Phatouros CC, Malek AM, Lempert TE, Dowd CF, Halbach VV. Cerebral hyperperfusion syndrome after percutaneous transluminal stenting of the craniocervical arteries. Neurosurgery. 2000;47:335-343.
109. Abou-Chebl A, Reginelli J, Bajzer CT, Yadav JS. Intensive treatment of hypertension decreases the risk of hyperperfusion and intracerebral hemorrhage following carotid artery stenting. Catheter Cardiovasc Interv. 2007;69:690-696.
110. Eckard DA, Zarnow DM, McPherson CM, Siegel EL, Eckard VR, Batnitzky S, Hermreck A. Intracranial internal carotid artery angio-plasty: technique with clinical and radiographic results and follow-up. AJR Am J Roentgenol. 1999;172:703-707.
111. Malek AM, Higashida RT, Phatouros CC, Lempert TE, Meyers PM, Gress DR, Dowd CF, Halbach VV. Treatment of posterior circulation ischemia with extracranial percutaneous balloon angioplasty and stent placement. Stroke. 1999;30:2073-2085.
112. Mori T, Kazita K, Mori K. Cerebral angioplasty and stenting for intra-cranial vertebral atherosclerotic stenosis. AJNR Am J Neuroradiol. 1999; 20:787-789.
113. Alazzaz A, Thornton J, Aletich VA, Debrun GM, Ausman JI, Charbel F. Intracranial percutaneous transluminal angioplasty for arteriosclerotic stenosis. Arch Neurol. 2000;57:1625-1630.
114. Gomez CR, Misra VK, Campbell MS, Soto RD. Elective stenting of symptomatic middle cerebral artery stenosis. AJNR Am J Neuroradiol. 2000;21:971-973.
115. Gomez CR, Misra VK, Liu MW, Wadlington VR, Terry JB, Tulyapronchote R, Campbell MS. Elective stenting of symptomatic basilar artery stenosis. Stroke. 2000;31:95-99.
116. Rasmussen PA, Perl J, Barr JD, Markarian GZ, Katzan I, Sila C, Krieger D, Furlan AJ, Masaryk TJ. Stent-assisted angioplasty of intracranial vertebrobasilar atherosclerosis: an initial experience. J Neurosurg. 2000; 92:771-778.
117. Levy EI, Horowitz MB, Koebbe CJ, Jungreis CC, Pride GL, Dutton K, Purdy PD. Transluminal stent-assisted angioplasty of the intracranial vertebrobasilar system for medically refractory, posterior circulation ischemia: early results. Neurosurgery. 2001;48:1215-1221.
118. Ramee SR, Dawson R, McKinley KL, Felberg R, Collins TJ, Jenkins JS, Awaad MI, White CJ. Provisional stenting for symptomatic intracranial stenosis using a multidisciplinary approach: acute results, unexpected benefit, and one-year outcome. Catheter Cardiovasc Interv. 2001;52: 457-467.
119. Abou-Chebl A, Bashir Q, Yadav JS. Drug-eluting stents for the treatment of intracranial atherosclerosis: initial experience and midterm angiographic follow-up. Stroke. 2005;36:e165-168.
120. Boulos AS, Agner C, Deshaies EM. Preliminary evidence supporting the safety of drug-eluting stents in neurovascular disease. Neurol Res. 2005; 27:S95-S102.
121. Chow MM, Masaryk TJ, Woo HH, Mayberg MR, Rasmussen PA. Stent-assisted angioplasty of intracranial vertebrobasilar atherosclerosis: midterm analysis of clinical and radiologic predictors of neurological morbidity and mortality. AJNR Am J Neuroradiol. 2005;26:869-874.
122. Marks MP, Marcellus ML, Do HM, Schraedley-Desmond PK, Steinberg GK, Tong DC, Albers GW. Intracranial angioplasty without stenting for symptomatic atherosclerotic stenosis: long-term follow-up. AJNR Am J Neuroradiol. 2005;26:525-530.
123. Suh DC, Kim SJ, Lee DH, Kim W, Choi CG, Lee JH, Kim HJ, Kwon SU, Kim JS. Outcome of endovascular treatment in symptomatic intra-cranial vascular stenosis. Korean J Radiol. 2005;6:1-7.
124. Tsumoto T, Terada T, Tsuura M, Matsumoto H, Masuo O, Yamaga H, Itakura T. Diffusion-weighted imaging abnormalities after percutaneous transluminal angioplasty and stenting for intracranial atherosclerotic disease. AJNR Am J Neuroradiol. 2005;26:385-389.
125. Yoon W, Seo JJ, Cho KH, Kim MK, Kim BC, Park MS, Kim TS, Kim JK, Kang HK. Symptomatic middle cerebral artery stenosis treated with intracranial angioplasty: experience in 32 patients. Radiology. 2005;237: 620-626.
126. Yu W, Smith WS, Singh V, Ko NU, Cullen SP, Dowd CF, Halbach VV, Higashida RT. Long-term outcome of endovascular stenting for symptomatic basilar artery stenosis. Neurology. 2005;64:1055-1057.
127. Mazighi M, Tanasescu R, Ducrocq X, Vicaut E, Bracard S, Houdart E, Woimant F. Prospective study of symptomatic atherothrombotic intra-cranial stenoses: the GESICA study. Neurology. 2006;66:1187-1191.
128. Terada T, Tsuura M, Matsumoto H, Masuo O, Tsumoto T, Yamaga H, Ohura Y, Itakura T. Hemorrhagic complications after endovascular therapy for atherosclerotic intracranial arterial stenoses. Neurosurgery. 2006;59:310-318.
129. de Rochemont Rdu M, Turowski B, Buchkremer M, Sitzer M, Zanella FE, Berkefeld J. Recurrent symptomatic high-grade intracranial stenoses: safety and efficacy of undersized stents-initial experience. Radiology. 2004;231:45-49.
130. Abou-Chebl A, Krieger DW, Bajzer CT, Yadav JS. Intracranial angio-plasty and stenting in the awake patient. J Neuroimaging. 2006;16: 216-223.
131. Bando K, Satoh K, Matsubara S, Nakatani M, Nagahiro S. Hyperper-fusion phenomenon after percutaneous transluminal angioplasty for atherosclerotic stenosis of the intracranial vertebral artery. Case report. J Neurosurg. 2001;94:826-830.
132. Gahn G, Richter A, Bourquain H, Hallmeyer S, Riechmann H, von Kummer R. Cerebrovascular reserve before and after vertebral artery angioplasty. AJNR Am J Neuroradiol. 1999;20:785-786.
133. Stehbens WE. Pathology of Cerebral Blood Vessels. St Louis: Mosby; 1972.
134. Ross MH, Romrell LJ, Kaye GI. Histology: A Text and Atlas. Baltimore: Williams & Wilkins; 1995.
135. Monson KL, Goldsmith W, Barbaro NM, Manley GT. Axial mechanical properties of fresh human cerebral blood vessels. J Biomech Eng. 2003; 125:288-294.
136. Tanriover N, Kawashima M, Rhoton AL Jr, Ulm AJ, Mericle RA. Microsurgical anatomy of the early branches of the middle cerebral artery: morphometric analysis and classification with angiographic correlation. J Neurosurg. 2003;98:1277-1290.
137. Canham PB, Finlay HM, Dixon JG, Boughner DR, Chen A. Measurements from light and polarised light microscopy of human coronary arteries fixed at distending pressure. Cardiovasc Res. 1989;23:973-982.
138. Holzapfel GA, Sommer G, Gasser CT, Regitnig P. Determination of layer-specific mechanical properties of human coronary arteries with nonatherosclerotic intimal thickening and related constitutive modeling. Am J Physiol Heart Circ Physiol. 2005;289:H2048-2058.
139. Walmsley JG, Campling MR, Chertkow HM. Interrelationships among wall structure, smooth muscle orientation, and contraction in human major cerebral arteries. Stroke. 1983;14:781-790.
140. Busby DE, Burton AC. The effect of age on the elasticity of the major brain arteries. Can J Physiol Pharmacol. 1965;43:185-202.
141. Hayashi K, Nagasawa S, Naruo Y, Okumura A, Moritake K, Handa H. Mechanical properties of human cerebral arteries. Biorheology. 1980; 17:211-218.
142. Fiorella D, Levy EI, Turk AS, Albuquerque FC, Niemann DB, Aagaard-Kienitz B, Hanel RA, Woo H, Rasmussen PA, Hopkins LN, Masaryk TJ, McDougall CG. US multicenter experience with the wingspan stent system for the treatment of intracranial atheromatous disease: peripro-cedural results. Stroke. 2007;38:881-887.
143. Al-Mubarak N, Gomez CR, Vitek JJ, Roubin GS. Stenting of symptomatic stenosis of the intracranial internal carotid artery. AJNR Am J Neuroradiol. 1998;19:1949-1951.
144. US Food and Drug Administration. WingSpan Stent System and Gateway PTA Balloon Catheter. Humanitarian Exception Device Approval Letter, August 3, 2005. Available at: www.fda.gov/cdrh/pdf5/h050001a.pdf. Accessed October 26, 2008.
145. Hahnel S, Ringleb P, Hartmann M. Treatment of intracranial stenoses using the Neuroform stent system: initial experience in five cases. Neuroradiology. 2006;48:479-485.
146. Lee SH, Jung JH, Shim WH. Endovascular treatment of basilar artery stenosis with drug-eluting stent: a case report and literature review. Catheter Cardiovasc Interv. 2005;64:296-300.
147. Gupta R, Al-Ali F, Thomas AJ, Horowitz MB, Barrow T, Vora NA, Uchino K, Hammer MD, Wechsler LR, Jovin TG. Safety, feasibility, and short-term follow-up of drug-eluting stent placement in the intra-cranial and extracranial circulation. Stroke. 2006;37:2562-2566.
148. Qureshi AI, Kirmani JF, Hussein HM, Harris-Lane P, Divani AA, Suri MF, Janjua N, Alkawi A. Early and intermediate-term outcomes with drug-eluting stents in high-risk patients with symptomatic intracranial stenosis. Neurosurgery. 2006;59:1044-1051; discussion 1051.
149. US Food and Drug Administration. FDA Statement on Coronary Drug-Eluting Stents, September 14, 2006. Available at: www.fda.gov/cdrh/news/091406.html. Accessed October 26, 2008.
150. Hirsh J, Guyatt G, Albers GW, Harrington R, Schtinemann HJ. Anti-thrombotic and thrombolytic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133(suppl 6):110S-112S.
151. Silber S, Albertsson P, Aviles FF, Camici PG, Colombo A, Hamm C, Jorgensen E, Marco J, Nordrehaug JE, Ruzyllo W, Urban P, Stone GW, Wijns W. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J. 2005;26:804-847.
152. Eisenstein EL, Anstrom KJ, Kong DF, Shaw LK, Tuttle RH, Mark DB, Kramer JM, Harrington RA, Matchar DB, Kandzari DE, Peterson ED, Schulman KA, Califf RM. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA. 2007;297: 159-168.
153. TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. N Engl J Med. 1985;312:932-936.
154. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, Pessin M, Ahuja A, Callahan F, Clark WM, Silver F, Rivera F. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA. 1999;282:2003-2011.
155. Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, Dillon W, Warach S, Broderick J, Tilley B, Sacks D. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke. 2003;34:e109-137.
156. Shigeyama J, Ito S, Kondo H, Ito O, Matsushita T, Okamoto M, Toyama J, Ban Y, Fukutomi T, Itoh M. Angiographic classification of coronary dissections after plain old balloon angioplasty for prediction of regression at follow-up. Jpn Heart J. 2001;42:393-408.
157. Mayberg MR, Batjer HH, Dacey R, Diringer M, Haley EC, Heros RC, Sternau LL, Torner J, Adams HP Jr, Feinberg W, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Circulation. 1994;90:2592-2605.
158. Broderick J, Connolly S, Feldmann E, Hanley D, Kase C, Krieger D, Mayberg M, Morgenstern L, Ogilvy CS, Vespa P, Zuccarello M. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Circulation. 2007;116: e391-413.
159. US Food and Drug Administration. WingSpan Stent System and Gateway PTA Balloon Catheter. Summary of Safety and Probable Benefit. Available at: www.fda.gov/cdrh/pdf5/h050001b.pdf. Accessed March 4, 2005.
160. Albers GW, Caplan LR, Easton JD, Fayad PB, Mohr JP, Saver JL, Sherman DG. Transient ischemic attack-proposal for a new definition. N Engl J Med. 2002;347:1713-1716.
161. The National Institute of Neurological Disorders rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med. 1995;333:1581-1587.
162. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Hoxter G, Mahagne MH. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA. 1995;274:1017-1025.
163. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, Larrue V, Bluhmki E, Davis S, Donnan G, Schneider D, Diez-Tejedor E, Trouillas P. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet. 1998;352:1245-1251.
164. Berger C, Fiorelli M, Steiner T, Schabitz WR, Bozzao L, Bluhmki E, Hacke W, von Kummer R. Hemorrhagic transformation of ischemic brain tissue: asymptomatic or symptomatic? Stroke. 2001;32: 1330-1335.
165. Liu AY, Do HM, Albers GW, Lopez JR, Steinberg GK, Marks MP. Hyperperfusion syndrome with hemorrhage after angioplasty for middle cerebral artery stenosis. AJNR Am J Neuroradiol. 2001;22:1597-1601.
166. Rezende MT, Spelle L, Mounayer C, Piotin M, Abud DG, Moret J. Hyperperfusion syndrome after stenting for intracranial vertebral stenosis. Stroke. 2006;37:e12-14.
167. Schoser BG, Heesen C, Eckert B, Thie A. Cerebral hyperperfusion injury after percutaneous transluminal angioplasty of extracranial arteries. J Neurol. 1997;244:101-104.
168. McCabe DJ, Brown MM, Clifton A. Fatal cerebral reperfusion hemorrhage after carotid stenting. Stroke. 1999;30:2483-2486.
169. Phatouros CC, Lefler JE, Higashida RT, Meyers PM, Malek AM, Dowd CF, Halbach VV. Primary stenting for high-grade basilar artery stenosis. AJNR Am J Neuroradiol. 2000;21:1744-1749.
170. Callahan AS III, Berger BL. Balloon angioplasty of intracranial arteries for stroke prevention. J Neuroimaging. 1997;7:232-235.
171. Barakate MS, Snook KL, Harrington TJ, Sorby W, Pik J, Morgan MK. Angioplasty and stenting in the posterior cerebral circulation. J Endovasc Ther. 2001;8:558-565.
172. Terada T, Nakai E, Tsuura M, Nakai K, Itakura T. Combined surgery and endovascular stenting for basilar artery stenosis refractory to balloon angioplasty: technical case report. Acta Neurochir (Wien). 2001;143:511-516.
173. Lee JH, Kwon SU, Suh DC, Kim JS. Percutaneous transluminal angio-plasty for symptomatic middle cerebral artery stenosis: long-term follow-up. Cerebrovasc Dis. 2003;15:90-97.
174. Zhang QZ, Miao ZR, Li SM, Zhu FS, Hua Y, Wang ML, Song QB, Ling F. Complications of stent-assistant angioplasty of symptomatic intra-cranial artery stenosis [in Chinese]. Zhonghua Yi Xue Za Zhi. 2003;83: 1402-1405.
175. Matsumaru Y, Tsuruta W, Takigawa T, Hyodo A, Sato H, Matsumura A. Percutaneous transluminal angioplasty for atherosclerotic stenoses of intracranial vessels. Interv Neuroradiol. 2004;10:17-20.
176. Liu JM, Hong B, Huang QH, Xu Y, Zhao WY, Zhang L, Zhao R, Zhou XP. Safety and short-term results of stent-assisted angioplasty for the treatment of intracranial arterial stenosis [in Chinese]. Zhonghua Wai Ke Za Zhi. 2004;42:169-172.
177. Lylyk P, Vila JF, Miranda C, Ferrario A, Musacchio A, Rufenacht D, Cohen JE. Endovascular reconstruction by means of stent placement in symptomatic intracranial atherosclerotic stenosis. Neurol Res. 2005; 27(suppl 1):S84-88.
178. Jiang WJ, Xu XT, Du B, Dong KH, Jin M, Wang QH, Ma N. Comparison of elective stenting of severe vs moderate intracranial atherosclerotic stenosis. Neurology. 2007;68:420-426.
179. Freitas JM, Zenteno M, Aburto-Murrieta Y, Koppe G, Abath C, Nunes JA, Raupp E, Hidalgo R, Pieruccetti MA, Lee A. Intracranial arterial stenting for symptomatic stenoses: a Latin American experience. Surg Neurol. 2007;68:378-386.
180. Fiorella D, Chow MM, Anderson M, Woo H, Rasmussen PA, Masaryk TJ. A 7-year experience with balloon-mounted coronary stents for the treatment of symptomatic vertebrobasilar intracranial atheromatous disease. Neurosurgery. 2007;61:236-242; discussion 242-243.